Research Article Open Access

Effect of Alkaloid Compound 3,6,7-trimethoxy-4-methyl-1,2,3,4- tetrahydro-isoquinoline of Swietenia macrophylla King Seed on Lipid Profile and Liver Tissue RBP4 Expression on Type 2-diabetes Rats

Authors

CORRESPONDING AUTHOR
Prasetyastuti
Department of Biochemistry, Faculty of Medicine, Universitas Gadjah Mada, Indonesia
|
Singgih Setiawan
Faculty of Medicine, Universitas Gadjah Mada, Indonesia
|
Yuwinda Prima Ardelia
Faculty of Medicine, Universitas Gadjah Mada, Indonesia
|
Tsurayya Fatma Hanifah
Faculty of Medicine, Universitas Gadjah Mada, Indonesia
|
Yunardi Singgo
Faculty of Medicine, Universitas Gadjah Mada, Indonesia
|
Sunarti
Department of Biochemistry, Faculty of Medicine, Universitas Gadjah Mada, Indonesia
Published on: October 15, 2016
DOI 10.3923/pjn.2016.975.979
PDF

Abstract

Background: Retinol Binding Protein 4 (RBP4) is adipocytokine that it’s secretion and expression in adipose tissue is highly correlated with glucose uptake and insulin sensitivity. Increasing of RBP4 in type 2-diabetes mellitus correlate with insulin resistence. Swietenia macrophylla king contain alkaloid, saponin and flavonoid. Objective: The aim of this study is to investigate the effect of 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline alkaloid compound of Swietenia macrophylla king seed to lipid profile and liver tissue RBP4 expression in type 2-diabetes rats. Methodology: Twenty five adult rattus norvegicus were used, five in each group. Group I: Diabetic rat (untreated), group II: Diabetic rat receive glibenclamid, group III: Diabetic rat receive 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline dose 10 mg/200 g b.wt., day–1, group IV: Diabetic rat receive 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline dose 20 mg/200 g b.wt., day–1 and group V: Diabetic rat receive 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline dose 40 mg/200 g b.wt., day–1. Blood samples were analysed for blood glucose, cholesterol, low density lipoprotein, triglyceride and high density lipoprotein level before and after 4 weeks treatment. At the end of the experiment sample of liver tissue were removed for immunohistochemical analysis. Results: Blood glucose level decreased significantly (p<0.05) in group II, III, IV and V. Cholesterol level decreased non-significantly (p>0.05), Low Density Lipoprotein (LDL) decreased significantly (p<0.05) at dose 40 mg/200 g b.wt. High Density Lipoprotein (HDL) level increased significantly (p<0.05) at doses 10 and 20 mg/200 g b.wt. Conclusion: However, the expression of Retinol Binding Protein 4 (RBP4) decreased after treatment with 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline. These results demonstrated that 3,6,7-trimethoxy-4-methyl-1,2,3,4-tetrahydro-isoquinoline increased HDL and decreased LDL and RBP4 expression.

Keywords:

Diabetes melitus, lipid profile, retinol binding protein 4, Swietenia macrophylla king

Article Metrics

115 Abstract Views
115 File Views
0 Downloads

License

Copyright (c) 2016 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Article Citation Metrics

Find Effect of Alkaloid Compound 3,6,7-trimethoxy-4-methyl-1,2,3,4- tetrahydro-isoquinoline of Swietenia macrophylla King Seed on Lipid Profile and Liver Tissue RBP4 Expression on Type 2-diabetes Rats on PlumX

How to Cite

Prasetyastuti, Setiawan, S., Ardelia, Y. P., Hanifah, T. F., Singgo, Y., & Sunarti. (2016). Effect of Alkaloid Compound 3,6,7-trimethoxy-4-methyl-1,2,3,4- tetrahydro-isoquinoline of Swietenia macrophylla King Seed on Lipid Profile and Liver Tissue RBP4 Expression on Type 2-diabetes Rats. Pakistan Journal of Nutrition, 15(11), 975–979. https://doi.org/10.3923/pjn.2016.975.979
Crossref
Scopus
Google Scholar
Europe PMC

References

1.
American Diabetes Association, 2014. Diagnosis and classification of diabetes mellitus. Diabetes care, 37: S81-S90.
2.
Cernea, S. and M. Dobreanu, 2013. Diabetes and beta cell function: From mechanisms to evaluation and clinical implications. Biochem. Med. (Zagreb), 23: 266-280.
3.
Yang, Q., T.E. Graham, N. Mody, F. Preitner and O.D. Peroni et al., 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436: 356-362.
4.
Ouchi, N., J.L. Parker, J.J. Lugus and K. Walsh, 2011. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol., 11: 85-97.
5.
Hajra, S., A. Mehta, P. Pandey and S.P. Vyas, 2011. Antioxidant and antidiabetic potential of ethanolic extract of Swietenia mahagoni (Linn.) seeds. Int. J. Pharm. Res. Dev., 3: 180-186.
6.
Mursiti, S., 2004. Identifikasi senyawa alkaloid dalam biji mahoni bebas minyak (Swietenia macrophylla King) dan efek biji mahoni terhadap penurunan kadar glukosa darah tikus putih (Rattus Novergicus). Universitas Gadjah Mada, Yogyakarta.
7.
Masiello, P., 2006. Animal models of type 2 diabetes with reduced pancreatic β-cell mass. Int. J. Biochem. Cell Biol., 38: 873-893.
8.
Mohammed, A., A.B. Adelaiye, M.S. Abubakar and E.M. Abdurahman, 2007. Effects of aqueous extract of Ganoderma lucidum on blood glucose levels of normoglycemic and alloxan-induced diabetic Wistar rats. J. Med. Plants Res., 1: 34-37.
9.
Iqbal, M., Kalsoom and S.A. Jafri, 2011. Effect of Punica granatum flowers extract on hypercholesterolemic and alloxan induced diabetic rats. Global J. Biotechnol. Biochem., 6: 83-86.
10.
Maiti, A., S. Dewanjee, G. Jana and S.C. Mandal, 2008. Hypoglycemic effect of Swietenia macrophylla seeds against type II diabetes. Int. J. Green Pharm., 2: 224-227.
11.
Falah, S., M. Safithri, T. Katayama and T. Suzuki, 2010. Hypoglycemic effect of mahogany (Swietenia macrophylla king) bark extracts in alloxan-induced diabetic rats. Wood Res. J., 1: 89-94.
12.
Lullman, H., M. Klaus, Z. Albrecht and B. Detlef, 2000. Color Atlas of Pahrmmacology. 2nd Edn., Thieme, New York.
13.
De, D., K. Chatterjee, K.M. Ali, T.K. Bera and D. Ghosh, 2011. Antidiabetic potentiality of the aqueous-methanolic extract of seed of Swietenia mahagoni (L.) Jacq. in streptozotocin-induced diabetic male albino rat: A correlative and evidence-based approach with antioxidative and antihyperlipidemic activities. Evid. Based Complem. Altern. Med.
14.
Carocho, M. and I.C.F.R. Ferreira, 2013. A review on antioxidants, prooxidants and related controversy: Natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem. Toxicol., 51: 15-25.
15.
Mooradian, A.D., 2009. Dyslipidemia in type 2 diabetes mellitus. Nat. Rev. Endocrinol., 5: 150-159.